Vericel (VCEL) EBT Margin (2011 - 2026)

Vericel (VCEL) reported EBT Margin of 9.99% for Q1 2026, up 1236.0% on a YoY basis from 0.75% in Q1 2025, and down 138.47% sequentially from 25.98% in Q4 2025.

Vericel (VCEL) EBT Margin (2011 - 2026) Analysis & Trends

Vericel (VCEL) has 16 years of EBT Margin data on file, last reported at 9.99% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 1236.0% year-over-year to 9.99%; the trailing twelve-month figure through Mar 2026 stood at 7.17% (up 627.0% YoY), and the FY2025 full-year result was 6.29%, up 186.0% from the prior year.
  • EBT Margin declined to 9.99% in Q1 2026, from 25.98% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.47% in Q4 2024 to a low of 121.69% in Q2 2023.
  • A 5-year average of 10.07% and a median of 8.66% in 2023 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin slumped 9735 bps in 2023 and jumped 11192 bps in 2024, its largest moves.
  • Tracing VCEL's EBT Margin over 5 years: stood at 12.57% in 2022, then jumped by 73 bps to 21.68% in 2023, then increased by 22 bps to 26.47% in 2024, then decreased by 2 bps to 25.98% in 2025, then slumped by 138 bps to 9.99% in 2026.
  • Business Quant data shows VCEL's EBT Margin at 9.99% in Q1 2026, 25.98% in Q4 2025, and 6.86% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn -9.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.99%
Dec 31, 2025 25.98%
Sep 30, 2025 6.86%
Jun 30, 2025 -1.58%
Mar 31, 2025 -22.36%
Dec 31, 2024 26.47%
Sep 30, 2024 -1.56%
Jun 30, 2024 -9.77%
Mar 31, 2024 -8.44%
Dec 31, 2023 21.68%
Sep 30, 2023 -8.66%
Jun 30, 2023 -121.69%
Mar 31, 2023 -19.41%
Dec 31, 2022 12.57%
Sep 30, 2022 -17.11%
Jun 30, 2022 -24.34%
Mar 31, 2022 -19.78%
Dec 31, 2021 8.84%
Sep 30, 2021 -14.62%
Jun 30, 2021 -9.40%